These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2203327

  • 1. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
    Bastani B, Nash JF, Meltzer HY.
    Arch Gen Psychiatry; 1990 Sep; 47(9):833-9. PubMed ID: 2203327
    [Abstract] [Full Text] [Related]

  • 2. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

  • 3. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 4. Blunted oral body temperature response to MK-212 in cocaine addicts.
    Lee MA, Meltzer HY.
    Drug Alcohol Depend; 1994 Jun; 35(3):217-22. PubMed ID: 7956751
    [Abstract] [Full Text] [Related]

  • 5. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL.
    Biol Psychiatry; 1991 Mar 01; 29(5):418-26. PubMed ID: 2018816
    [Abstract] [Full Text] [Related]

  • 6. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb 01; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 7. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb 01; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 8. Neuroendocrine responses to serotonergic agents in alcoholics.
    Lee MA, Meltzer HY.
    Biol Psychiatry; 1991 Nov 15; 30(10):1017-30. PubMed ID: 1756196
    [Abstract] [Full Text] [Related]

  • 9. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Int Clin Psychopharmacol; 1992 Nov 15; 7(1):45-9. PubMed ID: 1624756
    [Abstract] [Full Text] [Related]

  • 10. Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.
    Meltzer HY, Maes M.
    Biol Psychiatry; 1995 Sep 01; 38(5):310-8. PubMed ID: 7495925
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 12. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS, Westenberg HG.
    J Psychiatr Res; 2008 Sep 01; 42(11):894-901. PubMed ID: 18533183
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist.
    Lowy MT, Meltzer HY.
    Biol Psychiatry; 1988 Apr 15; 23(8):818-28. PubMed ID: 3365458
    [Abstract] [Full Text] [Related]

  • 14. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.
    Norman TR, Apostolopoulos M, Burrows GD, Judd FK.
    Int Clin Psychopharmacol; 1994 Apr 15; 9(2):89-94. PubMed ID: 8056999
    [Abstract] [Full Text] [Related]

  • 15. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC, Goodman WK, Price LH.
    Int Clin Psychopharmacol; 1993 Nov 15; 8 Suppl 2():79-82. PubMed ID: 8201248
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
    Meltzer H, Bastani B, Jayathilake K, Maes M.
    Neuropsychopharmacology; 1997 Jul 15; 17(1):1-11. PubMed ID: 9194044
    [Abstract] [Full Text] [Related]

  • 17. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL, McCracken JT, Cantwell DP.
    J Am Acad Child Adolesc Psychiatry; 1991 Mar 15; 30(2):173-8. PubMed ID: 2016218
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
    Hollander E, DeCaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR.
    Psychiatry Res; 1991 Jan 15; 36(1):1-17. PubMed ID: 2017519
    [Abstract] [Full Text] [Related]

  • 19. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR.
    Arch Gen Psychiatry; 1989 Jan 15; 46(1):23-8. PubMed ID: 2910220
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects.
    Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D.
    Psychiatry Res; 1998 Jul 13; 79(3):213-7. PubMed ID: 9704868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.